Alliancebernstein L.P. Axonics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Axonics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 879,161 shares of AXNX stock, worth $62.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

879,161

Previous 1,004,833 12.51%

Holding current value

$62.4 Million

Previous $67.6 Million 9.33%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $8.46 Million - $8.76 Million	-125,672 Reduced 12.51%	879,161 $61.3 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $14 Million - $14.6 Million	210,141 Added 26.44%	1,004,833 $67.6 Million
Q1 2024 May 14, 2024	BUY	$56.67 - $69.36 $41.9 Million - $51.2 Million	738,792 Added 1321.63%	794,692 $54.8 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $34,566 - $44,625	700 Added 1.27%	55,900 $3.48 Million
Q2 2023 Aug 15, 2023	BUY	$47.99 - $60.21 $287,940 - $361,260	6,000 Added 12.2%	55,200 $2.79 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $273,520 - $350,168	-5,200 Reduced 9.56%	49,200 $2.68 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $268,020 - $344,700	4,500 Added 9.02%	54,400 $3.4 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $21,870 - $31,380	500 Added 1.01%	49,900 $3.12 Million
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $30,006 - $44,010	-600 Reduced 1.2%	49,400 $2.77 Million
Q3 2021 Nov 10, 2021	SELL	$59.21 - $78.66 $76,973 - $102,258	-1,300 Reduced 2.53%	50,000 $3.26 Million
Q2 2021 Jul 30, 2021	BUY	$51.39 - $66.9 $200,421 - $260,910	3,900 Added 8.23%	51,300 $3.25 Million
Q1 2021 May 06, 2021	BUY	$49.14 - $59.89 $34,398 - $41,923	700 Added 1.5%	47,400 $2.84 Million
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $204,914 - $296,032	5,800 Added 14.18%	46,700 $2.38 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $421,544 - $732,872	18,400 Added 81.78%	40,900 $1.44 Million
Q4 2019 Feb 18, 2020	BUY	$19.57 - $28.96 $68,495 - $101,360	3,500 Added 18.42%	22,500 $623,000
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $83,452 - $131,471	3,100 Added 19.5%	19,000 $511,000
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $294,786 - $651,423	15,900 New	15,900 $651,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Axonics, Inc. Transaction History